10x Genomics director John R. Stuelpnagel disposes of USD 1.25 million in common shares - TXG News | Rallies10x Genomics director John R. Stuelpnagel disposes of USD 1.25 million in common shares
T
TXG• Director sells 19,000 Class A shares
- 10x Genomics director John R. Stuelpnagel sold 19,000 Class A common shares on Sept. 3, 2026.
- Sales were priced at a weighted average of USD 60.66 to USD 62.61 per share.
- His direct holding fell to 328,436 shares following the transactions.
NPKI
•
